NCT05573386 - Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

August 5, 2023

Study Completion Date

October 5, 2023

Conditions

Healthy

Interventions

DRUG

Filgrastim

human granulocyte colony-stimulating factor (G-CSF) protein obtained from the bacterial fermentation of a strain of E. coli. transformed with a genetically engineered plasmid containing the human G-CSF gene; administered via syringe

DRUG

Pegfilgrastim

long-acting covalent conjugate of recombinant methionyl human filgrastim and monomethoxypolyethylene glycol (PEG); administered via syringe

Trial Locations (1)

32561

Andrews Research and Education Foundation, Gulf Breeze